The University of Chicago Header Logo

Connection

Lynne Kaminer to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Lynne Kaminer has written about Antibodies, Monoclonal.
Lynne Kaminer
Connection Strength
0.048
Antibodies, Monoclonal
  1. Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98). Leuk Lymphoma. 2004 Oct; 45(10):2047-55.
    View in: PubMed
    Score: 0.037
  2. Oxaliplatin-related acute myelogenous leukemia. Oncologist. 2006 Mar; 11(3):261-2.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.